Cargando…

Lifestyle-mediated nitric oxide boost to prevent SARS-CoV-2 infection: A perspective

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and has seriously threatened public health by causing significant morbidity and mortality. Patients with coronavirus disease (COVID-19) with preexisting endothelial dysfunction caused by aging, diabetes, hypertensi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kobayashi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author. Published by Elsevier Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340570/ https://www.ncbi.nlm.nih.gov/pubmed/34364972 http://dx.doi.org/10.1016/j.niox.2021.08.001

Ejemplares similares

Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
por: Akaberi, Dario, et al.
Publicado: (2020)

Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide
por: Stefano, George B., et al.
Publicado: (2020)

Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro
por: Rousseaud, Audrey, et al.
Publicado: (2023)

Nasal prevention of SARS-CoV-2 infection by intranasal influenza-based boost vaccination in mouse models
por: Zhou, Runhong, et al.
Publicado: (2021)

Preventive measures and concern for SARS-CoV-2 infection associated with lifestyle changes in the Peruvian population
por: Chávez Sosa, Janett V., et al.
Publicado: (2023)

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
por: Lyke, Kirsten E., et al.
Publicado: (2023)

Waning and boosting of functional humoral immunity to SARS-CoV-2
por: Tong, X., et al.
Publicado: (2022)

Preventing the Adverse Effects of SARS-CoV-2 Infection and COVID-19 through Diet, Supplements, and Lifestyle
por: Lordan, Ronan, et al.
Publicado: (2021)

Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
por: Chiappalupi, Sara, et al.
Publicado: (2021)

Association among Lifestyle and Risk Factors with SARS-CoV-2 Infection
por: Ko, Yi, et al.
Publicado: (2023)

Exhaled nitric oxide is decreased in Sars-Cov-2 infection
por: Betancor, Diana, et al.
Publicado: (2022)

Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected
por: Åkerström, Sara, et al.
Publicado: (2009)

Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4(+) and CD8(+) T cells promote cellular immune responses
por: Huang, Jun, et al.
Publicado: (2007)

SARS-CoV-2 Vaccine in Dialysis Patients: Time for a Boost?
por: Krueger, Karen M., et al.
Publicado: (2022)

Boosting SARS-CoV-2 detection combining pooling and multiplex strategies
por: Correa, Isadora Alonso, et al.
Publicado: (2022)

SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing
por: Nunn, Alistair V. W., et al.
Publicado: (2020)

Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
por: Suhail, Shanzay, et al.
Publicado: (2020)

Nitric oxide‐mediated cutaneous microvascular function is not altered in middle‐aged‐to‐older adults following mild SARS‐CoV‐2 infection: A pilot study
por: Dillon, Gabrielle A., et al.
Publicado: (2023)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

SARS CoV2 infection _The longevity study perspectives
por: Lio, Domenico, et al.
Publicado: (2021)

Immunopharmacological perspective on zinc in SARS-CoV-2 infection
por: Asl, Sima Heydarzadeh, et al.
Publicado: (2021)

Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
por: Sheward, Daniel J., et al.
Publicado: (2021)

Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice
por: Zheng, Nuoyan, et al.
Publicado: (2009)

Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals
por: Berg, Michael G, et al.
Publicado: (2021)

SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients
por: Bizzotto, Juan, et al.
Publicado: (2020)

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
por: Anderson, Elizabeth M., et al.
Publicado: (2020)

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
por: Anderson, Elizabeth M., et al.
Publicado: (2021)

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection
por: Favresse, Julien, et al.
Publicado: (2023)

Application of “B+1” heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines
por: Liu, Zezhong, et al.
Publicado: (2023)

UDCA, a novel strategy for preventing SARS-CoV-2 infection via FXR-mediated ACE2 downregulation: UDCA and SARS-CoV-2 infection
por: Chen, Mengjiao, et al.
Publicado: (2023)

Prevention and Control Strategies for SARS-CoV-2 Infection
por: Srivastava, Nishant, et al.
Publicado: (2020)

Practical measures for SARS-CoV-2 infection prevention
por: Fujikawa, Tatsuya
Publicado: (2022)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
por: Liu, Hejun, et al.
Publicado: (2021)

A nidovirus perspective on SARS-CoV-2
por: Gulyaeva, Anastasia A., et al.
Publicado: (2021)

Structural and molecular perspectives of SARS-CoV-2
por: Kumar, Swatantra, et al.
Publicado: (2021)

The SARS-CoV-2 vaccines: Retrospective and perspectives
por: Epaulard, Olivier
Publicado: (2022)

SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
por: Petruk, Ganna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sppvlv9g37klt04kb53anq1jqo